Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Changes in Control, Board, and Management
SLNO logo

Soleno Therapeutics Goes Private in All-Cash Merger, Dissolving Board and Delisting from Nasdaq

SLNO8-KFiling Date: 5/18/2026
Soleno Therapeutics, Inc.
Description

What this story covers

Soleno Therapeutics completed a total transformation into a private subsidiary via an all-cash merger. This involved the entire board and executive team resigning, debt termination, and a full delisting from Nasdaq.

Story snapshot

CompanySoleno Therapeutics, Inc.
TickerSLNO
VariantStandard detailed
Duration4:46
Filing type8-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0001193125-26-228016
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in